The diagnosis of BCL2-R-negative, CD23+ follicle center lymphoma is challenging and must be differentiated from reactive conditions, nodal marginal zone lymphoma, and pediatric type follicular lymphoma. This evidence concerns the gene FCER2 and follicular lymphoma.